Leads to a New Agent (NUC-1031) in Clinical Development", JOURNAL OF MEDICINAL CHEMISTRY, vol.57, no.4, 27 February 2014 (2014-02-27), pages 1531-1542, XP055205033, ISSN: 0022-2623, DOI: 10.1021/jm401853a, Bilir A., Guneri A.D., Altinoz M.A.: "Acetaminophen and DMSO modulate growth and gemcitabine cytotoxicity in FM3A breast cancer cell s in vitro", NEOPLASMA, vol.51, no.61 January 2004 (2004-01-01), 2004, pages 460-464, XP055205686, Retrieved from the Internet: URL:http://www.elis.sk/download_file.php?p roduct_id=704&session_id=d4h527oor14r6t55q 2codkfqq1 [retrieved on 2015-07-31]

Enclosed is a translation of the patent claims in Norwegian. Please note that as per the Norwegian Patents Acts, section 66i the patent will receive protection in Norway only as far as there is agreement between the translation and the language of the application/patent granted at the EPO. In matters concerning the validity of the patent, language of the application/patent granted at the EPO will be used as the basis for the decision. The patent documents published by the EPO are available through Espacenet (http://worldwide.espacenet.com) or via the search engine on our website here: https://search.patentstyret.no/